These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33380663)

  • 1. Circulating annexin A2 as a biomarker in patients with pancreatic cancer.
    Karabulut M; Afsar CU; Serilmez M; Karabulut S
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S110-S115. PubMed ID: 33380663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma.
    Zhang HJ; Yao DF; Yao M; Huang H; Wu W; Yan MJ; Yan XD; Chen J
    World J Gastroenterol; 2012 Nov; 18(41):5897-904. PubMed ID: 23139605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma.
    Karabulut S; Afsar ÇU; Karabulut M; Alış H; Kılıc L; Çikot M; Yasasever CT; Aykan NF
    J Gastrointest Cancer; 2016 Mar; 47(1):47-54. PubMed ID: 26637231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating annexin A2 as a biomarker in gastric cancer patients: correlation with clinical variables.
    Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D
    Biomed Pharmacother; 2015 Feb; 69():237-41. PubMed ID: 25661364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma.
    El-Abd N; Fawzy A; Elbaz T; Hamdy S
    Tumour Biol; 2016 Jan; 37(1):211-6. PubMed ID: 26189841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer.
    Afsar CU; Karabulut M; Karabulut S; Ozal ST; Cikot M; Serilmez M; Tas F
    Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30544746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma.
    Zhang H; Yao M; Wu W; Qiu L; Sai W; Yang J; Zheng W; Huang J; Yao D
    Tumour Biol; 2015 Dec; 36(12):9373-83. PubMed ID: 26109000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of annexin II as a potential serum marker for hepatocellular carcinoma using a developed sandwich ELISA method.
    Ji NY; Park MY; Kang YH; Lee CI; Kim DG; Yeom YI; Jang YJ; Myung PK; Kim JW; Lee HG; Kim JW; Lee K; Song EY
    Int J Mol Med; 2009 Dec; 24(6):765-71. PubMed ID: 19885616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis.
    Chaudhary P; Gibbs LD; Maji S; Lewis CM; Suzuki S; Vishwanatha JK
    Breast Cancer Res; 2020 Jan; 22(1):11. PubMed ID: 31992335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum leptin levels may have diagnostic and predictive roles in patients with pancreatic adenocarcinoma treated with gemcitabine-based chemotherapy.
    Karabulut S; Usul Afsar C; Karabulut M; Alis H; Erturk K; Karaman S; Kones O; Bilgin E; Tas F
    J BUON; 2016; 21(4):895-902. PubMed ID: 27685911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Annexin A2 as a novel diagnostic serum biomarker for lung cancer.
    Yang J; Yang F; Nie J; Zou X; Tian H; Qin Y; Liu C
    Cancer Biomark; 2015; 15(2):205-11. PubMed ID: 25519022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.
    Sun Y; Gao G; Cai J; Wang Y; Qu X; He L; Liu F; Zhang Y; Lin K; Ma S; Yang X; Qian X; Zhao X
    Carcinogenesis; 2013 Mar; 34(3):595-604. PubMed ID: 23188673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum annexin A2 levels in acute brucellosis and brucellar spondylodiscitis.
    Aktug Demir N; Kolgelier S; Sumer S; Inkaya AC; Ozcimen S; Demir LS; Ural O; Arpaci A
    Eur J Clin Microbiol Infect Dis; 2014 Oct; 33(10):1855-9. PubMed ID: 24853056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer.
    Alonso-Alconada L; Santacana M; Garcia-Sanz P; Muinelo-Romay L; Colas E; Mirantes C; Monge M; Cueva J; Oliva E; Soslow RA; Lopez MA; Palacios J; Prat J; Valls J; Krakstad C; Salvesen H; Gil-Moreno A; Lopez-Lopez R; Dolcet X; Moreno-Bueno G; Reventos J; Matias-Guiu X; Abal M
    Int J Cancer; 2015 Apr; 136(8):1863-73. PubMed ID: 25219463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer.
    Hagiwara K; Harimoto N; Yokobori T; Muranushi R; Hoshino K; Gantumur D; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Araki K; Hosouchi Y; Shirabe K
    Ann Surg Oncol; 2020 Mar; 27(3):924-930. PubMed ID: 31463696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic and predictive value of serum CA19.9 in pancreatic cancer.
    Humphris JL; Chang DK; Johns AL; Scarlett CJ; Pajic M; Jones MD; Colvin EK; Nagrial A; Chin VT; Chantrill LA; Samra JS; Gill AJ; Kench JG; Merrett ND; Das A; Musgrove EA; Sutherland RL; Biankin AV;
    Ann Oncol; 2012 Jul; 23(7):1713-22. PubMed ID: 22241899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
    Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
    Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer.
    Choi CH; Chung JY; Chung EJ; Sears JD; Lee JW; Bae DS; Hewitt SM
    BMC Cancer; 2016 Jul; 16():448. PubMed ID: 27402115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma interleukin-11 (IL-11) levels have diagnostic and prognostic roles in patients with pancreatic cancer.
    Ren C; Chen Y; Han C; Fu D; Chen H
    Tumour Biol; 2014 Nov; 35(11):11467-72. PubMed ID: 25123265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered Serum Annexin A2 Might Be a New Potential Diagnostic Biomarker in Human Colorectal Cancer.
    Hu D; Shen B; Yu M; Zha X; Zhou Y; Chen F; Ren J; Zhang L
    Ann Clin Lab Sci; 2020 Nov; 50(6):726-733. PubMed ID: 33334786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.